Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2 — Stella

Recruiting

Back to PASC Post Acute Sequelae of COVID 19 trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Kennedy Krieger Institute, Baltimore, Maryland

Key details

Sponsor

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~200 participants

Started

July 2025

Primary completion

December 2029

Age range

18 Years – 75 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov